Retrospective analysis of aripiprazole augmentation and serotonin norepinephrine reuptake inhibitor switching in epilepsy patients with selective serotonin reuptake inhibitors-resistant depression
{{output}}
Depression is a significant comorbidity of epilepsy that affects both quality of life and seizure control. Selective serotonin reuptake inhibitors (SSRIs) are the recommended first-line treatment for depression in patients with epilepsy; however, the optimal m... ...
